Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

SAGE THERAPEUTICS, INC.

(SAGE)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su SAGE THERAPEUTICS, INC.
21/09SAGE THERAPEUTICS: Names Chris Benecchi as Chief Commercial Officer
21/09SAGE THERAPEUTICS: Appoints Chris Benecchi as Chief Commercial Officer
21/09Sage Therapeutics Appoints Chris Benecchi as Chief Commercial Officer
16/09SAGE THERAPEUTICS: Receives Fast Track Designation for SAGE-718 for the Treatment of Hunt..
15/09SAGE THERAPEUTICS: Receives US FDA Fast Track Designation for Potential Huntington's Dise..
15/09SAGE THERAPEUTICS: Receives Fast Track Designation for SAGE-718 for the Treatment of Hunt..
15/09Sage Therapeutics Receives Fast Track Designation for SAGE-718 for the Treatment of Hun..
15/09Sage Therapeutics Gets Fast-Track Designation for Huntington's Disease Treatment
02/09SAGE THERAPEUTICS: to Present at the Morgan Stanley Global Healthcare Conference
23/08AXSOME THERAPEUTICS: says U.S. FDA asks for no extra data for depression drug, shares sur..
11/08SAGE THERAPEUTICS: Insider Makes Significant Stock buy in Sage Therapeutics (SAGE) Shares..
09/08INSIDER TRENDS: Sage Therapeutics Insider 90-Day Buying Trend Continued with Purchase
04/08SAGE THERAPEUTICS: to Present at Upcoming August Investor Conferences
03/08SAGE THERAPEUTICS: Narrows Q2 Loss as Revenue Grows
03/08SAGE THERAPEUTICS: Management's Discussion and Analysis of Financial Condition and Result..
03/08Sage Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, ..
03/08SAGE THERAPEUTICS: Company announces REDWOOD and RAINFOREST Studies not expected to be re..
03/08SAGE THERAPEUTICS, INC.: Results of Operations and Financial Condition, Financial Stateme..
03/08SAGE THERAPEUTICS: Announces Second Quarter 2021 Financial Results and Highlights Pipelin..
23/07DGAP-NEWS: Il settore delle biotecnologie -2-
23/07DGAP-NEWS: Biotechbranche mit solidem 2. Quartal -2-
23/07PRESS RELEASE: Solid second quarter for the -2-
20/07SAGE THERAPEUTICS: to Report Second Quarter 2021 Financial Results on Tuesday, August 3, ..
09/07SAGE THERAPEUTICS: to Participate in Cowen's Psychedelics & Novel Mechanisms in Neuropsyc..
08/07SAGE THERAPEUTICS: to Participate in Cowen's Psychedelics & Novel Mechanisms in Neuropsyc..
25/06SAGE THERAPEUTICS: to Participate in SVB Leerink's 3rd Annual CNS Forum
25/06SAGE THERAPEUTICS, INC.(NASDAQGM: SAGE) dropped from Russell 1000 Growth Index
25/06SAGE THERAPEUTICS, INC.(NASDAQGM: SAGE) dropped from Russell 3000E Growth Index
25/06SAGE THERAPEUTICS, INC.(NASDAQGM: SAGE) dropped from Russell 3000 Growth Index
25/06SAGE THERAPEUTICS, INC.(NASDAQGM: SAGE) dropped from Russell Midcap Growth Index
25/06SAGE THERAPEUTICS, INC.(NASDAQGM: SAGE) dropped from Russell Small Cap Comp Growth Index
25/06SAGE THERAPEUTICS, INC.(NASDAQGM: SAGE) dropped from Russell 2500 Growth Index
24/06SAGE THERAPEUTICS: to Participate in SVB Leerink's 3rd Annual CNS Forum
19/06SAGE THERAPEUTICS: Insiders at Sage Therapeutics (SAGE) Make Significant purchases of Sto..
17/06Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone f..
17/06INSIDER TRENDS: Insider Purchase Continues Sage Therapeutics Positive Trend
17/06INSIDER TRENDS: Insider Purchase of Sage Therapeutics Stock Extends 90-Day Positive Trend
17/06INSIDER TRENDS: Sage Therapeutics Insider Awarded Stock, Exercises Derivative Security, P..
17/06NORTH AMERICAN MORNING BRIEFING: Markets Slip and -3-
16/06SAGE THERAPEUTICS: and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone an..
15/06Cracker Barrel, Sage Therapeutics fall; Ocugen, FedEx rise
15/06SECTOR UPDATE: Health Care Stocks Mixed Premarket Tuesday
15/06Les valeurs à suivre mardi 15 juin 2021 à Wall Street -
15/06BIOGEN: non pour la choroïdérémie, oui pour la dépression
15/06SAGE THERAPEUTICS: to Host Conference Call
15/06BIOGEN: données de phase III positives pour Zuranolone
15/06SAGE THERAPEUTICS: Biogen Say Zuranolone Study Meets Primary Endpoint in Patients With Ma..
15/06SAGE THERAPEUTICS: and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, a..
15/06SAGE THERAPEUTICS, INC.: Other Events, Financial Statements and Exhibits (form 8-K)
15/06SAGE THERAPEUTICS: depression drug meets late-stage study goal
15/06Sage, Biogen's Zuranolone Meets Primary Endpoint in Phase 3 Trial
10/06SAGE THERAPEUTICS, INC.: Submission of Matters to a Vote of Security Holders (form 8-K)
20/05SAGE THERAPEUTICS: Joins MTV Entertainment Group and More Than 1,300 Leading Organization..
13/05SAGE THERAPEUTICS TO HOST SAGE SCIEN: SAGE-718 In Depth
13/05SAGE THERAPEUTICS, INC. TO HOST SAGE: SAGE-718 In Depth
04/05SAGE THERAPEUTICS: Company on-track to initiate placebo-controlled Phase 2 trial with SAG..
04/05SAGE THERAPEUTICS: Q1 Net Loss Narrows
04/05SAGE THERAPEUTICS: Management's Discussion and Analysis of Financial Condition and Result..
04/05SAGE THERAPEUTICS, INC.: Results of Operations and Financial Condition, Financial Stateme..
04/05SAGE THERAPEUTICS: Announces First Quarter 2021 Financial Results and Highlights Pipeline..
04/05Sage Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, ..
28/04SAGE THERAPEUTICS: to Present at Upcoming May Investor Conferences
23/04DGAP-NEWS: BB BIOTECH AG: Le efficaci campagne di -2-
23/04DGAP-NEWS: BB BIOTECH AG: Erfolgreiche -2-
20/04SAGE THERAPEUTICS: to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021
12/04SAGE THERAPEUTICS: Biogen Drug Candidate's Phase 2 Study in Essential Tremor Meets Primar..
12/04Sage Therapeutics, Biogen Sees Positive Results for Essential Tremors Treatment
12/04SAGE THERAPEUTICS, INC.: Other Events, Financial Statements and Exhibits (form 8-K)
24/03SAGE THERAPEUTICS: to Present at the Stifel 3rd Annual CNS Day
18/03SAGE THERAPEUTICS, INC.: Other Events, Financial Statements and Exhibits (form 8-K)
17/03SAGE THERAPEUTICS, INC.: Change in Directors or Principal Officers (form 8-K)
17/03SAGE THERAPEUTICS: Reports Positive Data in Study of Depressive Disorder Drug Zuranolone
17/03SAGE THERAPEUTICS: Announces Continued Positive Zuranolone Data for Both 30 mg and 50 mg ..
17/03Sage Therapeutics, Inc. Announces Continued Positive Zuranolone Data for Both 30 Mg and..
16/03SAGE THERAPEUTICS: CFO to Step Down
1  2  3  4  5  6  7Pross.
Prossimo evento su SAGE THERAPEUTICS, INC.